Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 1, 2015, Pages 23.e9-23.e14

  Ho, Thai H ^a,b   Kapur, Payal ^c,d   Joseph, Richard W ^e   Serie, Daniel J ^e   Eckel Passow, Jeanette E ^b   Parasramka, Mansi ^e   Cheville, John C ^b   Wu, Kevin J ^e   Frenkel, Eugene ^c,d   Rakheja, Dinesh ^c,d   Stefanius, Karoliina ^c,d   Brugarolas, James ^c,d,f   Parker, Alexander S ^e  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

BRCA1 associated protein 1; Papillary; Polybromo 1; Renal cell carcinoma

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; PROTEIN; PROTEIN POLYBROMO 1; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PBRM1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NON CLEAR CELL RENAL CELL CARCINOMA; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; BIOSYNTHESIS; CARCINOMA, RENAL CELL; COHORT ANALYSIS; DEFICIENCY; GENETICS; KIDNEY NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84922590453     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.10.014     Document Type: Article

References (22)

1. Lopez-Beltran A., Carrasco J.C., Cheng L., et al. 2009 Update on the classification of renal epithelial tumors in adults. Int J Urol 2009, 16:432-443.
2. Varela I., Tarpey P., Raine K., et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011, 469:539-542.
3. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499:43-49.
4. Pena-Llopis S., Vega-Rubin-de-Celis S., Liao A., et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012, 44:751-759.
5. Dalgliesh G.L., Furge K., Greenman C., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363.
6. Joseph R.W., Kapur P., Serie D.J., et al. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer 2013, 120:1059-1067.
7. Gerlinger M., Horswell S., Larkin J., et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 2014, 46:225-233.
8. Dvorakova M., Dhir R., Bastacky S.I., et al. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up. Diagn Pathol 2010, 5(32):1-6.
9. Rohan S.M., Xiao Y., Liang Y., et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 2011, 24:1207-1220.
10. Chaux A., Albadine R., Schultz L., et al. Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas. Hum Pathol 2013, 44:2323-2330.
11. Eckel-Passow J.E., Lohse C.M., Sheinin Y., et al. Tissue microarrays: one size does not fit all. Diagn Pathol 2010, 5(48):1-10.
12. Gerlinger M., Rowan A.J., Horswell S., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
13. Pawlowski R., Muhl S.M., Sulser T., et al. Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer 2013, 132:E11-E17.
14. da Costa W.H., Rezende M., Rocha R.M., et al. PBRM1, a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma. BJU Int 2013, 113:E157-E163.
15. Kapur P., Christie A., Raman J.D., et al. BAP1 immunohistochemistry in a multi-institutional cohort predicts outcomes in patients with clear cell renal cell carcinoma. J Urol 2013, 191:603-610.
16. Kapur P., Pena-Llopis S., Christie A., et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 2013, 14:159-167.
17. Brugarolas J. PBRM1 and BAP1 as novel targets for renal cell carcinoma. Cancer J 2013, 19:324-332.
18. Linehan W.M., Srinivasan R., Schmidt L.S. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010, 7:277-285.
19. Albiges L., Guegan J., Le Formal A., et al. MET is a potential target across all papillary renal cell carcinomas. Result from a large molecular study of pRCC with CGHa and matching gene expression array. Clin Cancer Res 2014, 20:3411-3421.
20. Zhuang Z., Park W.S., Pack S., et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 1998, 20:66-69.
21. Hagenkord J.M., Gatalica Z., Jonasch E., et al. Clinical genomics of renal epithelial tumors. Cancer Genet 2011, 204:285-297.
22. Davis C.F., Ricketts C.J., Wang M., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 2014, 26:319-330.